To achieve effective treatment, it is imperative to regularly evaluate nighttime sleep quality and daytime sleepiness using instruments such as the PSQI and the ESS
Appendix A
All information presented in this website is intended for informational purposes only and not for the purpose of rendering medical advice
Thymosin 4 Affecting the Cytoskeleton Organization of the Myofibroblasts, Ehrlich HP, Hazard SW, Annals of the New York Academy of Sciences, 2012 Oct;1269:7478
Several large-scale cardiovascular outcome trials (including LEADER, SUSTAIN-6, and REWIND) have shown that certain GLP-1 receptor agonists liraglutide, semaglutide, and dulaglutide reduce the risk of major adverse cardiovascular events such as heart attack, stroke, and cardiovascular death in people with established cardiovascular disease or multiple cardiovascular risk factors